organization · Reporting owner
Medical Marijuana Inc
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AXIM BIOTECHNOLOGIES, INC.AXIM · Entity 9689 | 10% owner | December 31, 2016 | February 28, 2017 |
| NEUROPATHIX, INC.TYYG · Entity 126275 | 10% owner | July 25, 2018 | September 24, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AXIM BIOTECHNOLOGIES, INC.
Report date December 31, 2016 · Filed February 28, 2017 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,669,125 |
Reported balance
After 2016-12-02 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2016-12-02 · Grant · Acquired 7,200,000 · Balance 22,669,125 F1: Reporting person is the owner of MJNA Investment Holdings, LLC which holds 17,969,125 shares of common stock. |
| Preferred StockSEC Table I · non-derivative | Direct | 500,000 |
Reported balance
After 2016-11-21 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2016-11-21 · Grant · Acquired 500,000 · Balance 500,000 F2: Reporting person holds 500,000 shares of Series C Preferred Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Reporting person is the owner of MJNA Investment Holdings, LLC which holds 17,969,125 shares of common stock.
F2: Reporting person holds 500,000 shares of Series C Preferred Stock.
NEUROPATHIX, INC.
Report date July 25, 2018 · Filed September 24, 2018 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series A Convertible Preferred StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2018-07-25 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance Not disclosed F1: Each share of convertible preferred stock is convertible at any time, at the holder's election, into 1,000 shares of common stock of the issuer and has no expiration date. F2: On August 6, 2018, the reporting person mistakenly filed a Form 3 reporting a purchase of 75,000 shares of Series A Convertible Preferred Stock that did not in fact occur. The reporting person does not own any shares of Series A Convertible Preferred Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of convertible preferred stock is convertible at any time, at the holder's election, into 1,000 shares of common stock of the issuer and has no expiration date.
F2: On August 6, 2018, the reporting person mistakenly filed a Form 3 reporting a purchase of 75,000 shares of Series A Convertible Preferred Stock that did not in fact occur. The reporting person does not own any shares of Series A Convertible Preferred Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 02, 2016 Filed Feb 15, 2017 21:01 UTC | AXIM BIOTECHNOLOGIES, INC. AXIM · Entity 9689 | GrantCommon Stock | 7,200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000218 · primary_doc.xml · nonDerivative · entry 1 Medical Marijuana Inc · CIK 0001604964 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,143,650 F1 · ownership.direct: Reporting person is the owner of MJNA Investment Holdings, LLC which holds 17,443,650 shares of common stock. Read SEC document |
| December 02, 2016 Filed Feb 28, 2017 19:11 UTC Amendment | AXIM BIOTECHNOLOGIES, INC. AXIM · Entity 9689 | GrantCommon Stock | 7,200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000274 · primary_doc.xml · nonDerivative · entry 1 Medical Marijuana Inc · CIK 0001604964 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,669,125 F1 · ownership.direct: Reporting person is the owner of MJNA Investment Holdings, LLC which holds 17,969,125 shares of common stock. Read SEC document |
| November 21, 2016 Filed Feb 15, 2017 21:01 UTC | AXIM BIOTECHNOLOGIES, INC. AXIM · Entity 9689 | GrantPreferred Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000218 · primary_doc.xml · nonDerivative · entry 2 Medical Marijuana Inc · CIK 0001604964 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 F2 · ownership.direct: Reporting person holds 500,000 shares of Series C Preferred Stock. Read SEC document |
| November 21, 2016 Filed Feb 28, 2017 19:11 UTC Amendment | AXIM BIOTECHNOLOGIES, INC. AXIM · Entity 9689 | GrantPreferred Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000274 · primary_doc.xml · nonDerivative · entry 2 Medical Marijuana Inc · CIK 0001604964 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 F2 · ownership.direct: Reporting person holds 500,000 shares of Series C Preferred Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.